Download SmartTRAK's Interview Transcript
VIVEX Biologics’ CEO Pete Wehrly discusses how VIVEX’ diverse portfolio of regenerative solutions in orthopedics and wound care can potentially turn the regenerative medicine industry on its ear with an eye towards proving, through economic and clinical evidence, that its technologies are better than anything on the market today. To find out more about the Company, its technologies and what’s next in terms of clinical research and reimbursement, download our interview transcript!
